Cancer Research SABCS  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 869-875, March 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleischmann, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleischmann, W. R., Jr.

Potentiation of the Direct Anticellular Activity of Mouse Interferons: Mutual Synergism and Interferon Concentration Dependence1

W. Robert Fleischmann, Jr.

Department of Microbiology, The University of Texas Medical Branch, Galveston, Texas 77550

Mouse immune (IFN-{gamma})2 and virus-type (IFN-{alpha}/ß) interferons were used separately and in combination in cloning studies with B-16 melanoma cells. IFN-{gamma} was found to be a more potent mediator of the direct anticellular effect of interferon than was IFN-{alpha}/ß, as shown not only by a greater sensitivity of B-16 cells to IFN-{gamma} but also by a steeper slope of the anticellular sensitivity curve of the IFN-{gamma}. The differences in the slopes of the curves defining their anticellular effect appeared to be inherent in the interferons themselves and not due to an inhibitor of interferon, a stimulator of cell growth, or another factor possessing anticellular activity. The results are consistent with the interpretation that IFN-{gamma} and IFN-{alpha}/ß exert their anticellular effects by different mechanisms. The anticellular activity of interferon against B-16 melanoma replication unit development was potentiated by mixed preparations of IFN-{gamma} and IFN-{alpha}/ß. The potentiation appeared to be an expression of a property of the interferons themselves. Replication units resistant to the potentiated activity of the interferons were not detected. Potentiation levels were dependent on the concentrations of both IFN-{gamma} and IFN-{alpha} and continued to increase dramatically as the interferon concentrations increased. Maximum potentiation observed was 214-fold at the highest interferon concentrations used. The data suggest that potentiation is a mutual, synergistic interaction of IFN-{gamma} and IFN-{alpha}/ß.

1 Supported by USPHS Grant 5R01 CA 26475 awarded by the Department of Health and Human Services, National Cancer Institute.

Received 8/ 3/81. Accepted 11/30/81.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A.-S.A. Ismail, C. J. Van Groeningen, A. Hardcastle, Q.-F. Ren, G. W. Aherne, F. Geoffroy, C. J. Allegra, and J. L. Grem.
Modulation of Fluorouracil Cytotoxicity by Interferon-alpha and -gamma
Mol. Pharmacol., February 1, 1998; 53(2): 252 - 261.
[Abstract] [Full Text]


Home page
JAMAHome page
T. C. Merigan
Interferon--The First Quarter Century
JAMA, November 19, 1982; 248(19): 2513 - 2516.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.